spacer
home > pmps > winter 2002 > the barrier essentials
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Barrier Essentials

Unit-dose blister packaging represents one of the fastest-growing segments of pharmaceutical packaging today. Worldwide, blister packaging sales surpassed those of plastic bottles by $20 million in 2001, and The Freedonia Group, a market research firm, sees that gap widening. It predicts that demand for blister packages will reach $1 billion - compared with $905 million for plastic bottles - by 2006.

Widely popular throughout Europe, where nearly 85 per cent of all solid drugs are dispensed in it, blister packaging has earned greater global acceptance as consumers have come to appreciate its advantages. For one, blister packaging is more portable than bottles. Moreover, it provides clear evidence of product tampering and can help reduce the possibility of accidental misuse by children.

Pharmaceutical manufacturers have also realised important benefits from blister packaging. They have found, for instance, that it aids patient compliance by helping consumers follow dosing regimens and presenting visual reminders of doses taken, making their drugs more effective. In addition, it can maintain the integrity of the entire packaged product by providing barrier protection that guards each individual dose against moisture, light or air from the time it is packaged until the time it is used by consumers.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Mohan Sasthav PhD, Segment Manager, Packaging at MeadWestvaco Packaging Resources Group
Mohan Sasthav was recently named Segment Manager, Packaging for the Packaging Resources Group (PRG) of MeadWestvaco Corp. He received his PhD in Chemical Engineering at the University of Akron, Ohio in 1993.

In that same year, he started at MeadWestvaco and worked in Corporate Research & Development for eight years focusing on the functionality of paperboard, specifically in barrier and high strength packaging. Currently, Mohan is pursuing an MBA.

spacer
Mohan Sasthav
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Specialized expertise that gives you an inside edge

Tap into the knowledge of specialists with decades of experience identifying and solving difficult challenges. From technical obstacles such as siliconization and lyophilization to strategic issues such as life cycle planning, Vetterís integrated team approach brings together the right experts for your compoundís precise requirements.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement